CUMBERLAND PHARMACEUTICALS INC
CPIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001087294
Insider trades, last 90 days
None
- No open-market purchases or sales were filed in the last 90 days.
13F holders, Q2 2026
32
- +3 vs. Q1 2026
- Total value $16M
Superinvestors holding CPIX
0
- None of the superinvestors held CPIX at the end of Q2 2026.
Price chart
Latest insider trades
View all: Latest insider tradesOpen-market purchases and sales by CPIX insiders, newest first.
| Filed (ET) | Trade date | Insider | Transaction | Shares | Avg price | Value | Shares after | Holding change | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2025 | Aug 1 – Aug 29, 2025 | Young CarolineDirector | PPurchaseCommon Stock | +121 | $3.2883 | +$397.89 | 32.94K | +0.4% | SEC10b5-1 |
| Sep 12, 2025 | Aug 1 – Aug 29, 2025 | Jones JamesDirector | PPurchaseCommon Stock | +262 | $3.2884 | +$861.57 | 43.94K | +0.6% | SEC10b5-1 |
| Sep 12, 2025 | Aug 1 – Aug 29, 2025 | KAZIMI A JChairman and CEO | PPurchaseCommon Stock | +262 | $3.2884 | +$861.57 | 5.7M | 0.0% | SEC10b5-1 |
| Sep 12, 2025 | Aug 1 – Aug 29, 2025 | Krogulski KennethDirector | PPurchaseCommon Stock | +1.37K | $3.2917 | +$4.52K | 289.72K | +0.5% | SEC10b5-1 |
| Aug 11, 2025 | Jul 1 – Jul 31, 2025 | Young CarolineDirector | PPurchaseCommon Stock | +168 | $3.4399 | +$577.9 | 32.82K | +0.5% | SEC |
Top 5 13F holders, Q2 2026
View all: Top 5 13F holders, Q2 2026The largest institutional positions in CPIX at the end of Q2 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ikarian Capital, LLC | 503,153 | $3.26M | 0.53% | −50,000−9.0% | Reduced |
| RENAISSANCE TECHNOLOGIES LLC | 478,263 | $3.1M | 0.00% | +7,567+1.6% | Added |
| VANGUARD CAPITAL MANAGEMENT LLC | 379,478 | $2.46M | 0.00% | +17,719+4.9% | Added |
| DIMENSIONAL FUND ADVISORS LP | 233,305 | $1.51M | 0.00% | −43,054−15.6% | Reduced |
| BOOTHBAY FUND MANAGEMENT, LLC | 112,544 | $729.29K | 0.01% | −15,150−11.9% | Reduced |